| You are in:Home/Publications/Next-generation nanoformulation: Glycyrrhiza glabra-based chitosan–curcumin MgO/Fe₂O₃ nanocomposite for targeted lung cancer therapy with dual antioxidant action | |
Dr. Sara Metwally Abdallah Mohamed Abdelsayed :: Publications: |
|
| Title: | Next-generation nanoformulation: Glycyrrhiza glabra-based chitosan–curcumin MgO/Fe₂O₃ nanocomposite for targeted lung cancer therapy with dual antioxidant action |
| Authors: | A Elmetwalli; S Abdelsayed; A Elsayed; M S El-Hersh; M G Hassan; L A Gad; M A Salah; M B Yahia; M A Shaheen; M F Ibrahim; A M Ibrahim; H M Newish; E Alhomaidi; A H El-Far; K M Elattar |
| Year: | 2026 |
| Keywords: | Nanoformulation; Glycyrrhiza glabra; chitosan–curcumin; MgO/Fe₂O₃ nanocomposite; lung cancer; antioxidant activity |
| Journal: | Medical Oncology |
| Volume: | 42 |
| Issue: | Not Available |
| Pages: | 414 |
| Publisher: | Springer Nature |
| Local/International: | International |
| Paper Link: | |
| Full paper | Sara Metwally Abdallah Mohamed Abdelsayed_NextgenerationnanoformulationGlycyrrhizaglabrabased (1).pdf |
| Supplementary materials | Not Available |
| Abstract: |
This study reports a next-generation nanoformulation based on Glycyrrhiza glabra, integrating chitosan–curcumin with MgO/Fe₂O₃ nanocomposites for targeted lung cancer therapy. The nanoformulation demonstrated enhanced anticancer efficacy alongside dual antioxidant activity, highlighting its potential as a multifunctional therapeutic platform for lung cancer treatment. |
